Literature DB >> 17545515

DNA copy number gains at loci of growth factors and their receptors in salivary gland adenoid cystic carcinoma.

Hedy Vékony1, Bauke Ylstra, Saskia M Wilting, Gerrit A Meijer, Mark A van de Wiel, C René Leemans, Isaäc van der Waal, Elisabeth Bloemena.   

Abstract

PURPOSE: Adenoid cystic carcinoma (ACC) is a malignant salivary gland tumor with a high mortality rate due to late, distant metastases. This study aimed at unraveling common genetic abnormalities associated with ACC. Additionally, chromosomal changes were correlated with patient characteristics and survival. EXPERIMENTAL
DESIGN: Microarray-based comparative genomic hybridization was done to a series of 18 paraffin-embedded primary ACCs using a genome-wide scanning BAC array.
RESULTS: A total of 238 aberrations were detected, representing more gains than losses (205 versus 33, respectively). Most frequent gains (>60%) were observed at 9q33.3-q34.3, 11q13.3, 11q23.3, 19p13.3-p13.11, 19q12-q13.43, 21q22.3, and 22q13.33. These loci harbor numerous growth factor [fibroblast growth factor (FGF) and platelet-derived growth factor (PDGF)] and growth factors receptor (FGFR3 and PDGFRbeta) genes. Gains at the FGF(R) regions occurred significantly more frequently in the recurred/metastasized ACCs compared with indolent ACCs. Furthermore, patients with 17 or more chromosomal aberrations had a significantly less favorable outcome than patients with fewer chromosomal aberrations (log-rank = 5.2; P = 0.02).
CONCLUSIONS: Frequent DNA copy number gains at loci of growth factors and their receptors suggest their involvement in ACC initiation and progression. Additionally, the presence of FGFR3 and PDGFRbeta in increased chromosomal regions suggests a possible role for autocrine stimulation in ACC tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17545515     DOI: 10.1158/1078-0432.CCR-06-2555

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  19 in total

Review 1.  Molecular biology of adenoid cystic carcinoma.

Authors:  Jia Liu; Chunbo Shao; Marietta L Tan; David Mu; Robert L Ferris; Patrick K Ha
Journal:  Head Neck       Date:  2011-10-17       Impact factor: 3.147

2.  Comprehensive analysis of the MYB-NFIB gene fusion in salivary adenoid cystic carcinoma: Incidence, variability, and clinicopathologic significance.

Authors:  Yoshitsugu Mitani; Jie Li; Pulivarthi H Rao; Yi-Jue Zhao; Diana Bell; Scott M Lippman; Randal S Weber; Carlos Caulin; Adel K El-Naggar
Journal:  Clin Cancer Res       Date:  2010-08-11       Impact factor: 12.531

3.  Genetic profile of adenoid cystic carcinomas (ACC) with high-grade transformation versus solid type.

Authors:  Ana Flávia Costa; Albina Altemani; Hedy Vékony; Elisabeth Bloemena; Florentino Fresno; Carlos Suárez; José Luis Llorente; Mario Hermsen
Journal:  Cell Oncol (Dordr)       Date:  2011-05-04       Impact factor: 6.730

4.  Detailed genome-wide SNP analysis of major salivary carcinomas localizes subtype-specific chromosome sites and oncogenes of potential clinical significance.

Authors:  Li Zhang; Yoshitsugu Mitani; Carlos Caulin; Pulivarthi H Rao; Merrill S Kies; Pierre Saintigny; Nianxiang Zhang; Randal S Weber; Scott M Lippman; Adel K El-Naggar
Journal:  Am J Pathol       Date:  2013-04-10       Impact factor: 4.307

5.  A phase II study of axitinib (AG-013736) in patients with incurable adenoid cystic carcinoma.

Authors:  A L Ho; L Dunn; E J Sherman; M G Fury; S S Baxi; R Chandramohan; S Dogan; L G T Morris; G D Cullen; S Haque; C S Sima; A Ni; C R Antonescu; N Katabi; D G Pfister
Journal:  Ann Oncol       Date:  2016-08-26       Impact factor: 32.976

Review 6.  Fibroblast growth factor signalling: from development to cancer.

Authors:  Nicholas Turner; Richard Grose
Journal:  Nat Rev Cancer       Date:  2010-02       Impact factor: 60.716

Review 7.  Adenoid cystic carcinoma: clinical and molecular features.

Authors:  Christopher A Moskaluk
Journal:  Head Neck Pathol       Date:  2013-03-05

8.  FGFR3 mutations, but not FGFR3 expression and FGFR3 copy-number variations, are associated with favourable non-muscle invasive bladder cancer.

Authors:  Yann Neuzillet; Bas W G van Rhijn; Nadia L Prigoda; Bharati Bapat; Liyang Liu; Peter J Bostrom; Neil E Fleshner; Brenda L Gallie; Alexandre R Zlotta; Michael A S Jewett; Theo H van der Kwast
Journal:  Virchows Arch       Date:  2014-06-01       Impact factor: 4.064

9.  Induction of autophagy-dependent cell death by the survivin suppressant YM155 in salivary adenoid cystic carcinoma.

Authors:  Yu-Fan Wang; Wei Zhang; Ke-Fei He; Bing Liu; Lu Zhang; Wen-Feng Zhang; Ashok B Kulkarni; Yi-Fang Zhao; Zhi-Jun Sun
Journal:  Apoptosis       Date:  2014-04       Impact factor: 5.561

10.  The mutational landscape of adenoid cystic carcinoma.

Authors:  Allen S Ho; Kasthuri Kannan; David M Roy; Luc G T Morris; Ian Ganly; Nora Katabi; Deepa Ramaswami; Logan A Walsh; Stephanie Eng; Jason T Huse; Jianan Zhang; Igor Dolgalev; Kety Huberman; Adriana Heguy; Agnes Viale; Marija Drobnjak; Margaret A Leversha; Christine E Rice; Bhuvanesh Singh; N Gopalakrishna Iyer; C Rene Leemans; Elisabeth Bloemena; Robert L Ferris; Raja R Seethala; Benjamin E Gross; Yupu Liang; Rileen Sinha; Luke Peng; Benjamin J Raphael; Sevin Turcan; Yongxing Gong; Nikolaus Schultz; Seungwon Kim; Simion Chiosea; Jatin P Shah; Chris Sander; William Lee; Timothy A Chan
Journal:  Nat Genet       Date:  2013-05-19       Impact factor: 38.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.